Cardiac imaging AI company Heartflow raised $364 million from an upsized public stock offering, far exceeding expectations.
Key Details
- 1Heartflow is an imaging AI vendor specializing in noninvasive CT-based cardiac tests.
- 2The company raised $364 million from its IPO, up from the original $100 million target.
- 3Shares were sold at $19 each, with over 19 million shares issued.
- 4Heartflow uses CT data to generate personalized 3D models of coronary arteries.
- 5The company reported $126 million in revenue last year, growing 44% year-over-year.
- 6Estimated market opportunity for Heartflow's products exceeds $5 billion.
Why It Matters
This large capital raise highlights both investor confidence and strong demand for AI-powered cardiac imaging solutions. The funding will help Heartflow expand its reach among radiologists and further develop its imaging AI technology.
Source
Radiology Business
Related News
•AuntMinnie
Deep Learning AI Outperforms Radiologists in Detecting ENE on CT
A deep learning tool, DeepENE, exceeded radiologist performance in identifying lymph node extranodal extension in head and neck cancers using preoperative CT scans.
•Radiology Business
FDA Clears Multi-Disease AI Screening Platform for CT Imaging
HeartLung Corporation's AI-CVD platform receives FDA clearance to detect multiple diseases from a single CT scan.
•Radiology Business
Imaging AI Systems Could Play Key Role in Future Pandemic Response
A study finds that repurposed AI detection tools in radiology could help address future pandemics more effectively.